CFDE Data Portal | Search SCGB1D2

	Label	Description
	SCGB1D2 associations Collection (Entity type)	Associations for SCGB1D2_associations
	SCGB1D2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE195663 cisplatin 7 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE125862 2 V 1 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 fulvestrant 10 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS
	SCGB1D2 Gene (Entity type)	ENSG00000124935 - secretoglobin family 1D member 2
	GSE216540 1 V 6 FULVESTRANT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE120210 GSE120214 TBXT brachyury inhibition 1 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216540 10 V 6 FULVESTRANT HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 4 V 0 RUXOLITINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

SCGB1D2 associations

Associations for SCGB1D2_associations

SCGB1D2 associations.tsv

A file from IDG as part of the Harmonizome project

GSE195663 cisplatin 7 v 1 human up

A Gene Set from LINCS

GSE125862 2 V 1 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE216540 fulvestrant 10 v 6 human up

A Gene Set from LINCS

SCGB1D2

ENSG00000124935 - secretoglobin family 1D member 2

GSE216540 1 V 6 FULVESTRANT HUMAN UP

A Gene Set from LINCS

GSE120210 GSE120214 TBXT brachyury inhibition 1 v 5 human up

A Gene Set from LINCS

GSE216540 10 V 6 FULVESTRANT HUMAN UP

A Gene Set from LINCS

GSE193351 4 V 0 RUXOLITINIB HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.